Mol Imaging Biol. 2024 Apr;26(2):360-369. doi: 10.1007/s11307-024-01900-6. Epub 2024 Feb 15. ABSTRACT PURPOSE: To assess the prognostic value of pre-treatment Ga-PSMA-11 PET/CT and other baseline clinical characteristics in predicting prostate cancer (PCa) patients response to Lu-PSMA (PSMA-I&T), as well as…
Intraductal Prostate Cancer Affinity for Lymphatic-Predominant Metastases Through (18)F-DCFPyL-Prostate-Specific Membrane Antigen-Positron Emission Tomography/CT Scans in Pretreatment Prostate Cancer Patients
J Urol. 2024 Apr;211(4):586-593. doi: 10.1097/JU.0000000000003850. Epub 2024 Feb 1. ABSTRACT PURPOSE: Intraductal prostate cancer (IDC) is linked to unfavorable oncologic outcomes, marked by distinctive cellular intrinsic pathway changes and intricate immunosuppressive microenvironments that could impact the way cancer spreads.…